Used primarily in pharmaceutical research as an intermediate in the synthesis of selective serotonin reuptake inhibitors (SSRIs) and related central nervous system agents. Its structure supports the development of compounds targeting neurological pathways involved in mood regulation. The presence of bromine and dimethylamino groups allows for further functionalization in drug design, making it valuable in creating analogs for antidepressant and anxiolytic medications. It is also employed in studies exploring receptor binding affinity and metabolic stability of psychoactive compounds.